共 68 条
- [1] Busse WW(2008)The Inhaled Steroid Treatment As Regular Therapy in Early Asthma (START) study 5-year follow-up: effectiveness of early intervention with budesonide in mild persistent asthma J Allergy Clin Immunol 121 1167-1174
- [2] Pedersen S(2008)Effect of disease duration on dose-response of inhaled budesonide in asthma Respir Med Dis 102 1065-1072
- [3] Pauwels RA(2014)International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma Eur Respir J 43 343-373
- [4] Tan WC(2015)The prevalence of severe refractory asthma J Allergy Clin Immunol 135 896-902
- [5] Chen YZ(2011)The pharmacogenetics and pharmacogenomics of asthma therapy Pharmacogenomics J 11 383-392
- [6] Lamm CJ(2000)Heterogeneity of therapeutic responses in asthma Br Med Bull 56 1054-1070
- [7] O'Byrne PM(2009)Pharmacogenetics of asthma Curr Opin Pulm Med 15 57-62
- [8] Selroos O(2017)Effects of genetic factors to inhaled corticosteroid response in children with asthma: a literature review J Int Med Res 45 1818-1830
- [9] Chung KF(2016)Study of the correlations between FENO in exhaled breath and atopic status, blood eosinophils, FCER2 mutation, and asthma control in Vietnamese children J Asthma Allergy 9 163-170
- [10] Hekking PP(2012)Genome-wide association identifies the T gene as a novel asthma pharmacogenetic locus Am J Respir Crit Care Med 185 1286-1291